When anti-TNF fails, anti-IL12-23 is an alternate option in psoriasis and psoriatic arthritis
- PMID: 25054605
When anti-TNF fails, anti-IL12-23 is an alternate option in psoriasis and psoriatic arthritis
Abstract
Patients with psoriasis and psoriatic arthritis respond to anti-TNF therapy, but not all patients maintain effective response, and some do not respond. In this article, we demonstrate the role of a new pathogenetic pathway to some extent TNF-independent in these patients. Anti-IL12-23 is a new and alternate mode of therapy for patients with recalcitrant response to anti-TNF.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
